Selank 10mg

CLASSIFICATION
Anxiolytic Peptide
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
Selank

In recent years, the field of biotechnology has unveiled a fascinating array of biologically active substances, particularly in the realm of cognitive enhancers, commonly known as nootropics. One standout example is Selank, previously known as ?TP-7.? This synthetic peptide is engineered to provide powerful benefits, acting as an effective anti-anxiety agent while enhancing cognitive function and energy levels without the risk of side effects or addiction.

Developed through a collaboration between the Institute of Molecular Genetics (Russian Academy of Sciences) and the V.V. Zakusov Research Institute of Pharmacology, Selank is a smaller, more manageable peptide compared to traditional proteins. It combines sequences from tuftsin, a naturally occurring peptide that plays a role in immune function, with elements that enhance its stability.

Research indicates that both tuftsin and Selank are capable of reducing anxiety and boosting serotonin levels in animal models, with Selank showing slightly superior effectiveness. In Russia, Selank is approved for the treatment of generalized anxiety disorder (GAD) and as a nootropic, although it has not yet received FDA approval. In various countries, it is often marketed as a nutritional supplement.

While the exact mechanisms of Selank remain somewhat elusive, it is believed to stabilize enkephalins in the bloodstream, which are natural peptides that help reduce stress. Some studies suggest that Selank may interact with GABA receptors, typically associated with calming effects. Animal research has shown that Selank can increase activity in GABA-dependent inhibitory neurons, leading to reduced overall brain activity, which aligns with sedative effects.

Notably, Selank has also been linked to increased levels of BDNF, a crucial neurotrophic factor associated with learning and memory, suggesting it may enhance cognitive performance. Additionally, it has been observed to influence neurotransmitters such as norepinephrine, dopamine, and serotonin in mice?key players in motivation, focus, and pleasure. Although findings vary across studies, they indicate that Selank impacts these important brain chemicals.

In preliminary clinical trials with 62 participants, those treated with Selank reported a notable decrease in anxiety symptoms, particularly among individuals with existing anxiety disorders. Further trials involving patients with anxiety and phobias showed lasting benefits even a week after treatment. Moreover, Selank has been found to enhance the effects of phenazepam, an anti-anxiety medication, while minimizing side effects like drowsiness and memory loss. In animal studies, Selank has consistently demonstrated its ability to alleviate anxiety, especially in those with higher baseline anxiety levels.

Research has indicated that Selank may stabilize memory traces in rats over a 30-day period, although the methods of measurement remain unclear. Additionally, some studies suggest potential memory preservation in monkeys, yet human research is limited, and further investigations are needed to clarify its effects on healthy individuals.

In a notable study, Selank was shown to restore normal brain activity levels in rats with toxin-induced brain damage.

Selank has demonstrated a capacity to reduce symptoms of depression in mice, particularly at lower doses, as measured by reduced immobility in forced swimming tests.

Animal studies suggest that Selank injections can elevate antioxidant levels in the livers of stressed mice, indicating potential protective effects.

In sedated cats, Selank administration reduced blood pressure by about 30% for up to three minutes and increased cerebral blood flow by approximately 24% for ten minutes. While these findings indicate short-term cardiovascular effects, they require further validation in healthy human subjects.

Amid alcohol withdrawal, anxiety can be a significant concern. Research on rats suggests that Selank may alleviate anxiety levels following 48 hours of withdrawal from alcohol.

Animal studies have shown that Selank may reduce weight gain by 35% in rats on a high-fat diet, alongside significant reductions in total cholesterol and blood glucose levels.

Preliminary findings indicate that Selank may slow tumor growth in breast cancer-infected mice, but extensive research is necessary before considering it as a viable cancer therapy. It should never replace standard cancer treatments.

Post-treatment with Selank, mice exhibited higher levels of inflammatory response genes in their spleens, suggesting potential protective effects against inflammation-related damage.

Selank has been associated with a reduction in stomach ulcer size in animal models, and some researchers propose it may enhance lymph flow to the stomach, which is vital for immune function. Nevertheless, more human studies are needed to confirm these effects.

Selank has been linked to increased IL-6 production in blood cells from depressed patients, playing a role in inflammation and immune responses. Additionally, it has been shown to promote the release of interferons, which are known for their antiviral properties. However, one animal study did not find any antiviral benefits, indicating that more research is needed to explore this potential.